Email this article A new class of nitric oxide donors
- Authors: Aldoshin S.M.1, Sanina N.A.1, Davydov M.I.2, Chazov E.I.3
-
Affiliations:
- Institute of Problems of Chemical Physics
- Blokhin Russian Cancer Research Center
- Russian Cardiology Research and Production Complex
- Issue: Vol 86, No 3 (2016)
- Pages: 158-163
- Section: Scientific Session of the General Meeting of the Russian Academy of Sciences
- URL: https://journals.rcsi.science/1019-3316/article/view/178688
- DOI: https://doi.org/10.1134/S1019331616030096
- ID: 178688
Cite item
Open Access
Access granted
Subscription Access
Abstract
This article deals with a new class of nitric oxide donors—safe medications for the treatment of socially significant diseases. This complex work has been performed in collaboration with a number of RAS institutes, the Russian Cardiology Research and Production Complex, and the Blokhin Russian Cancer Research Center.
About the authors
S. M. Aldoshin
Institute of Problems of Chemical Physics
Author for correspondence.
Email: smaldoshin@presidium.ras.ru
Russian Federation, Chernogolovka, Moscow oblast
N. A. Sanina
Institute of Problems of Chemical Physics
Email: smaldoshin@presidium.ras.ru
Russian Federation, Chernogolovka, Moscow oblast
M. I. Davydov
Blokhin Russian Cancer Research Center
Email: smaldoshin@presidium.ras.ru
Russian Federation, Moscow
E. I. Chazov
Russian Cardiology Research and Production Complex
Email: smaldoshin@presidium.ras.ru
Russian Federation, Moscow
